All
Erleada Improves Survival in Prostate Cancer Subset
February 1st 2019In topline findings from the phase 3 TITAN trial (NCT02489318) announced today by Janssen, Erleada (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved radiographic progression-free survival (rPFS) and overall survival (OS) versus placebo in patients with metastatic castration-sensitive prostate cancer.
Flat and OK With That: How Societal Pressures Are Placed on Breast Cancer Survivors
January 31st 2019The pressures of society can overwhelm the woman with breast cancer. These feelings of inadequacy and unacceptance can be compounded by the physical disfigurement left behind by breast cancer surgery.
FDA Expands Alimta Approval for Use With Immunotherapy and Chemo in Lung Cancer
January 31st 2019The FDA has expanded the indication for Alimta (pemetrexed) injection in combination with Keytruda (pembrolizumab) and platinum-based chemotherapy for the first-line treatment of patients with metastatic nonsquamous non–small cell lung cancer (NSCLC) without EGFR or ALK alterations.
Cancer and Peripheral Neuropathy
January 26th 2019I keep fumbling and dropping lids to water bottles and other items. When I climb the stairs to my apartment, I often feel like I am going to fall backwards and grab the rail. If I go out in the cold air, my fingers tingle for hours afterwards. What in the world is wrong with me?